Ravindra Uppaluri

Stereotactic Body Radiotherapie With Pembrolizumab in Programmed Cell Death Protein 1 Inhibitor–Refractory Recurrent or Gemetastaseerd Hoofd-hals Squamous Cell Carcinoma: A Fase 2-Trial

Neoadjuvant and Adjuvant Pembrolizumab in Locally Gevorderd Head and Neck Cancer.

Neoadjuvant nivolumab of nivolumab-ipilimumab bij mondholtecarcinoom: gerandomiseerde fase II